Drug and Market Development PublishingDrug & Market Development Publications, a division of Informa Group plc, publishes D&MD Newsletter and D&MD Reports. Our publications are designed to bring detailed, comprehensive business and technology information to pharmaceutical and biotechnology executives working in R&D, business development and marketing.D&MD Newsletter is monthly newsletter designed to help track the R&D developments and asses market trends of the pharmaceutical and biotechnology field, featuring regular features on:
|
 |
List of reports from Drug and Market Development Publishing
|
Fluorescent Proteins: Technologies, Applications, and Opportunities for Drug Discovery
8/24/2004 | published by: Drug and Market Development Publishing
... for fluorescent proteins, and future perspectives on fluorescent proteins. In addition, the intellectual property landscape in this area is summarized, companies invested in fluorescent protein drug discovery are profiled, and key industry players are interviewed.
|
more...
|
$2,995.00
|
|
Tissue MicroArrays: Emerging Business Opportunities and Applications Driving the Marketplace
8/19/2004 | published by: Drug and Market Development Publishing
... overview of the industry, qualitative analysis of the market, and a quantitative examination of the market opportunities. In addition, several companies - both large and small - active in the tissue microarrays market are profiled.
|
more...
|
$4,950.00
|
|
Drug Transporters and ADME Pharmacological and Commercial Implications
8/1/2004 | published by: Drug and Market Development Publishing
... R&D. Over the last 15 years, a heterogeneous group of proteins, collectively known as drug transporters, emerged as critical determinants of ADME for many drugs. Understanding drug transporters is critical to the analysis of a ...
|
more...
|
$2,995.00
|
|
Vaccines in the 21st Century: New Approaches, Targets, and Market Vitality
6/30/2004 | published by: Drug and Market Development Publishing
... innovation that impacts efficacy, safety, quality, or delivery, to provide a unique look at the larger realm of prospects. In addition, topical profiles of all major vaccine companies; including M&A activity, research pipelines, market penetration, ...
|
more...
|
$4,950.00
|
|
High-Growth Infectious Disease Markets
6/28/2004 | published by: Drug and Market Development Publishing
... disease segment, the current and prospective technologies are identified and products and applications are reviewed. A series of detailed profiles of companies active in these markets is followed by in-depth interviews with four industry experts.
|
more...
|
$2,995.00
|
|
Cell Signalling Pathways:Productive Sources of Pharmaceutical Targets
6/1/2004 | published by: Drug and Market Development Publishing
... loss of control at any stage usually results in disease. This report will provide an overview of what is currently known about critical signalling pathways, highlighting the proteins and interactions that go awry in disease, ...
|
more...
|
$4,950.00
|
|
Peptide Therapeutics: Applications in the Treatment of Human Diseases
4/1/2004 | published by: Drug and Market Development Publishing
... peptides, their potential applications in the treatment of human diseases, and recent technology developments. In addition, the intellectual property landscape is reviewed, companies invested in peptide development are profiled, and key industry players are interviewed.
|
more...
|
$2,995.00
|
|
Transdermal and Transmucosal Therapeutics: New Developments in Drug Delivery
4/1/2004 | published by: Drug and Market Development Publishing
... potential market for transdermal and transmucosal drug delivery. In addition, the intellectual property landscape in this area is summarized, companies invested in transdermal and transmucosal drug delivery are profiled, and key industry players are interviewed.
|
more...
|
$2,995.00
|
|
A Guide to Competitive Intelligence for the Life Sciences Industry
3/1/2004 | published by: Drug and Market Development Publishing
... business, as well as protect themselves against competing companies who will try to access the same information from you. Most importantly, this Guide focuses on the life sciences, and unique business issues within this industry ...
|
more...
|
$395.00
|
|
Metabolic Syndrome: New Opportunities in Diagnostics and Therapeutics
2/28/2004 | published by: Drug and Market Development Publishing
... prediabetic states), lipid abnormalities, and hypertension. In addition, the Report reviews drugs and in vitro diagnostics - both existing products and product candidates - expected to fuel the growth of the emerging metabolic syndrome market.
|
more...
|
$4,950.00
|
|
Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets
2/18/2004 | published by: Drug and Market Development Publishing
... their classification, role in diseases, role in signal transduction, and as potential targets for developing therapeutics. The intellectual property landscape is reviewed, companies invested in phosphatase development are profiled, and key industry players are interviewed.
|
more...
|
$2,995.00
|
|
Systems Biology:Key to Unlocking the Value within the Omics Revolution
1/1/2004 | published by: Drug and Market Development Publishing
... provided and the technical and commercial background is detailed. The nature of systems biology is examined in its several manifestations; commercial applications in pharmaceutical, diagnostic, and other business segments; and market dynamics. A series of ...
|
more...
|
$2,995.00
|
|
Lead Optimization: A Reinvention of the Process
11/10/2003 | published by: Drug and Market Development Publishing
... The Report discusses cutting-edge methods, such as computational ADME/Tox, cell-based systems, pharmacogenomics, and metabonomics, along with several case studies in lead optimization. In addition, this Report reviews companies that supply lead optimization tools/services plus assesses ...
|
more...
|
$2,995.00
|
|
Nuclear Receptors: Key Targets for New Pharmaceuticals
11/3/2003 | published by: Drug and Market Development Publishing
... of the nuclear receptor family and discusses their potential as drug targets. In addition, the Report provides an overview of nuclear receptor physiology, highlighting the potential of each receptor as a target for pharmaceutical development.
|
more...
|
$4,950.00
|
|
High Density Multiplexed Assays: Obstacles & Opportunities for Bioscience Markets
8/9/2003 | published by: Drug and Market Development Publishing
... high density multiplexed assay technologies becoming a major player in disease and patient stratification over the next five years, especially in major areas such as cancer—making it essential reading for those decision-makers in the pharmaceutical, ...
|
more...
|
$2,995.00
|
|
Protein Arrays: Commercial Opportunities, Legal Trends, and Technology Analyses
6/30/2003 | published by: Drug and Market Development Publishing
... analysis. In addition, this Report reviews how protein arrays offer biotechnology and pharmaceutical companies the opportunity to examine biological targets en masse and therefore discover protein marker signatures/patterns of biological significance. The importance of this ...
|
more...
|
$4,950.00
|
|
Protein Kinases: Technologies and Opportunities for Drug Discovery
6/6/2003 | published by: Drug and Market Development Publishing
... play a key role. In addition, this Report reviews the current trends in kinase drug discovery, highlights promising proprietary approaches to target identification, target validation, lead generation, and lead optimization, and identifies issues of special ...
|
more...
|
$4,950.00
|
|
Chiral Technologies: Commercial Opportunities of Today & the Future
5/1/2003 | published by: Drug and Market Development Publishing
... discusses various business models and strategies, and the various issues which impinge on them. Instructive case studies offer insight into how these various business models and strategies have been formulated within this industry. In addition, ...
|
more...
|
$4,950.00
|
|
Cell-Based Assays: Commerical Opportunities, Legal Trends, & Technology Analyses
4/1/2003 | published by: Drug and Market Development Publishing
... qualitative analysis of the market, and a quantitative examination of the market opportunity (in various sub-sectors of cell-based assays). We also examine the intellectual property issues implicit in the development and use of cell-based assays.
|
more...
|
$4,950.00
|
|
A Guide to Assay Development
3/1/2003 | published by: Drug and Market Development Publishing
... to speed and simplify development and optimization of almost technologies. This Guide eliminates the tendency to "reinvent the wheel" by providing valuable tips that incorporate the author's many years of hands-on experience in the field.
|
more...
|
$295.00
|
|
Cell Therapy - Technologies, Markets, and Opportunities
2/1/2003 | published by: Drug and Market Development Publishing
... and technologies corporations are employing to capture their share of this growing market. This informative Report answers many important questions, including what diseases will significantly benefit from current and future research, how regulatory and ethical ...
|
more...
|
$4,950.00
|
|
A Guide to Building and Managing Successful Strategic Alliances
10/1/2002 | published by: Drug and Market Development Publishing
... also takes into account that such alliances, as all other relationships between individuals or corporations, are not only a purely intellectual or economical matter but often require human qualities such as mediation, diplomacy, and understanding.
|
more...
|
$295.00
|
|
A Guide to Due Diligence in Life Science Transactions
9/1/2002 | published by: Drug and Market Development Publishing
... as well as checklists readily employable in day-to-day business operations. Most importantly, this Guide focuses on the life sciences, and unique business issues within this industry that are not covered in any other comparable publication.
|
more...
|
$295.00
|
|
Pain Therapeutics - A New Era of Research Innovations and Commerical Opportunities
7/1/2002 | published by: Drug and Market Development Publishing
... into the problem of pain, examines the current approaches to treatment, and delves into the tools and methods being utilized in the development of more effective drugs. In addition, this Report offers a thorough assessment ...
|
more...
|
$4,950.00
|
|
A Guide to Evaluating and Choosing CROs
6/1/2002 | published by: Drug and Market Development Publishing
... D&MD's Guide to Evaluating and Choosing CROs provides essential guidance for securing the correct outsourcing option. In addition, you'll find the information you need to make the right deal and facilitate co-operation with all partners.
|
more...
|
$295.00
|
